Research Accelerator for Follicular Lymphoma – I (RAFL – I) Translational Grant (TRL)
The Leukemia & Lymphoma Society & The Institute for Follicular Lymphoma Innovation (IFLI)
The overall goal of the TRL award mechanism is to reduce the time between laboratory findings and actual clinical utility, putting research on the bench-to-bedside fast track when it comes to finding better treatment and cures for follicular lymphoma. TRL awards will support translational research that moves potential therapeutic candidates toward clinical trials within two to 3 years of the five year award period.
Funding available up to $350,000 USD per year for up five years.
The Application must be submitted electronically to LLS Research portal.
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Letter of Intent |
| 09-Sep-2024 3:00 pm EST |
Application (Upon Invitation Only) | 02-Jan-2025 4:30 pm CST | 13-Jan-2025 3:00 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.